Page 1383 - Problem-Based Feline Medicine
P. 1383
DRUG INDEX
20 – THE CAT WITH ENLARGED LYMPH NODES 13751375
infusion 5–7 days, then 24 until remission, then to min. effective 4–6 wk, then halve dosage Continued
to effect 7 days 12–24 12–24 1–2 Rx 3 days/wk 12 for taper dose 12 for
8 12 12 hr 12 12 12 12 12 12 24 12 8–12 or for
PO PO IV IV PO IA PO PO PO PO PO PO PO PO IM IM IV IV PO PO PO PO PO
20–40 mg/kg 50 mg/cat 10–20 ml/kg 0.5–1.5 g/kg 0.22 mg/kg 3–5 mg/cat 0.5 mg/kg titrate up to 0.5–0.8 mg/kg 2.5 mg; up to 10 mg/cat 0.5–2.0 mg/kg 0.5–5.0 mg/kg 2–4 mg/kg 2 mg/kg 0.5–1.0 mg/kg 2.5–5.0 mg/kg 0.1–0.2 mg/kg 2–4 mg/kg 8–20 mg/kg 50–150 mg/kg 5–10 ml/cat 25–30 mg/kg 0.5 g/m 2 15 mg/kg 0.5 g/m 2
Plasma volume expander Immune-mediated diseases Antitussive Synovitis failure Vasodilator: heart Antihypertensive agent Nephrogenic diabetes insipidus Hypoglycemia Calcium oxalate uroliths therapy Replacement Anti-inflammatory Hypoadrenocorticism Immune mediated hemolytic anemia Shock Emetic Primary polycythemia Chronic granulocytic leukemia
Hetastarch (Hydroxyethyl starch) Human gamma globulin Hycodan (hydrocodone) Hyaluronate Na Hydralazine Hydrochlorothiazide Hydrocortisone Hydrocortisone aurate Hydrocortisone sodium succinate Hydrogen peroxide 3% Hydroxyurea